SWOG clinical trial number
SWOG-9503 (NCCTG-93-72-52)

Phase III Trial of BCNU and Cisplatin Versus BCNU Alone and Standard Radiation Therapy Versus Accelerated Radiation Therapy in Patients with Grade 4 Glioma.

Closed
Phase
Published
Abbreviated Title
Phase III Trial of BCNU and Cisplatin Versus BCNU Alone and Standard Radiation Therapy Versus Accelerated Radiation Therapy in Patients with Grade 4 Glioma.
Activated
06/01/1995
Closed
06/18/1999

Publication Information Expand/Collapse

2006

Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation terapy or accelertaed radiation therapy in patients with glioblastoma multiformed: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 trials

J Buckner;K Ballman;JCK Michalak;GV Burton;TL Cascino;PJ Schomberg;RB Hawkins;B Scheithauer;HM Sandler;RS Marks;JR O'Fallon Journal of Clinical Oncology 24(24:3871-3879)

PMid: PMID16921039

2001

Phase III trial of BCNU and cisplatin (CDDP) versus BCNU alone and standard radiation therapy (SRT) versus accelerated radiation therapy (ART) in glioblastoma (GBM) patients (PTS): NCCTG/SWOG results

JC Buckner;JC Michalak;PJ Schomberg;GV Burton;HM Sandler;TL Cascino;RB Hawkins;BW Scheithauer;JR O'Fallon Proc of the American Society of Clinical Oncology 20:51a(#202)